NCT05916313
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05916313
Title A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ESP | DEU | CHE | AUT

Facility Status City State Zip Country Details
University of California Irvine Orange California 92868 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Salzburg Cancer Research Institute Salzburg 5020 Austria Details
Universitätsklinikum Frankfurt Frankfurt 60596 Germany Details
Klinikum der Universität München AÖR München 81377 Germany Details
Universitätsklinikum Tübingen Tübingen 72076 Germany Details
Erasmus Medisch Centrum-ROTTERDAM-50697 Rotterdam 3015 GD Netherlands Details
Hospital del Mar Barcelona 08003 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Cantonal Hospital of Aarau Aarau CH-5001 Switzerland Details
University Hospital of Lausanne Lausanne 1101 Switzerland Details
University Hosp. Zurich Zurich 8901 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field